First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome

NCT03594955 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
7
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision

Conditions

Interventions

Sponsor

Sanofi